Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.

BMC pregnancy and childbirth - 10 Mar 2010

Sedano-Balbás Sara, Lyons Mark, Cleary Brendan, Murray Margaret, Gaffney Geraldine, Maher Majella

Abstract excerpt

BACKGROUND: Activated Protein C Resistance (APCR), a poor anticoagulant response of APC in haemostasis, is the commonest heritable thrombophilia. Adverse outcomes during pregnancy have been linked to APCR. This study determined the frequency of APCR, factor V gene known and novel SNPs and adverse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Abortion, Spontaneous
Share to Activated Protein C Resistance
Share to Fetal Growth Retardation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ireland

Share to Pre-Eclampsia

Share to Pregnancy Complications, Hematologic

Share to Pregnancy Outcome

Share to Prohibitins

Source

Open in PubMed Open full text

Identifiers

PMID: 20214832
DOI: 10.1186/1471-2393-10-11
PMCID: PMC2853494

Genes

APC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20214832-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women.PMID 20214832Read ↗

Acquired activated protein C resistance, thrombophilia and adverse pregnancy outcomes: a study performed in an Irish cohort of pregnant women.Semantic proximity Read ↗

Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.Semantic proximity Read ↗

Inherited thrombophilias and adverse pregnancy outcomes: a case–control study in an Australian populationSemantic proximity Read ↗

Obstetric implications of activated protein C resistance and factor V Leiden mutation.Semantic proximity Read ↗

Germline mutations in the alternative pathway of complement predispose to HELLP syndrome.Semantic proximity Read ↗

Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.Semantic proximity Read ↗

Activated Protein C Resistance and Factor V Leiden Mutation can be Associated with First‐ as well as Second‐Trimester Recurrent Pregnancy Loss1Semantic proximity Read ↗

A gene-centric analysis of activated partial thromboplastin time and activated protein C resistance using the HumanCVD focused genotyping array.Semantic proximity Read ↗

Mutations in the thrombomodulin and endothelial protein C receptor genes in women with late fetal loss.Semantic proximity Read ↗

Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis.Semantic proximity Read ↗

Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation.Semantic proximity Read ↗

Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.